Active specific immunotherapy potential for the treatment of large bowel cancer
Active specific immunotherapy, harnessing the strength and specificity of the host immune response to destroy neoplastic cells, may offer an ideal surgical adjuvant treatment modality for human colon cancer. Unfortunately, achievement of this goal has been obscured by 1) the effect of excess residua...
Gespeichert in:
| Veröffentlicht in: | Cancer 1977-11, Vol.40 (S5), p.2740-2746 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2746 |
|---|---|
| container_issue | S5 |
| container_start_page | 2740 |
| container_title | Cancer |
| container_volume | 40 |
| creator | Kahan, Barry D. Pellis, Neal R. Rutzky, Lynne P. Wiseman, Floyd Tom, Baldwin H. |
| description | Active specific immunotherapy, harnessing the strength and specificity of the host immune response to destroy neoplastic cells, may offer an ideal surgical adjuvant treatment modality for human colon cancer. Unfortunately, achievement of this goal has been obscured by 1) the effect of excess residual disease to interfere with the host's destructive response, 2) the weak nature of tumor resistance, 3) the potential adverse effect of concomitant treatments such as chemotherapy, and 4) the present limitation of poorly defined immunogens to induce, as well as insensitive assay systems to detect, host sensitization. Recent immunologic and chemical research revealing distinctive surface membrane structures on colon cancer cells suggests that a controlled trial of irradiated, autochthonous cell vaccines (without mycobacterial adjuvants) may provide a new therapeutic tool for Dukes B2 and C stages of human colon cancer. |
| doi_str_mv | 10.1002/1097-0142(197711)40:5+<2740::AID-CNCR2820400949>3.0.CO;2-V |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73725103</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73725103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4639-b6143a7c740f087e9a962fddc286b2cfee9c169b560186c728f307020f8eb96e3</originalsourceid><addsrcrecordid>eNqNkFtv1DAQhS3EbSn8Ax78hKhQlrGdxHFBlZZwq1SxEoIK8TJyvGNIlWyCnaXaf4-XVJXgAfE08pzxOTMfY68ELAWAfC7A6AxELp8Ko7UQxzmcFM9eSp3qyersdVZ_qD_KSkIOYHJzqpawrNcvZHZxiy1uPt9mCwCosiJXX-6zBzFepqeWhbrH7hopk--CrVduan8SjyO51reOt32_2w7Tdwp23PNxmGg7tbbjfgg8dfkUyE59avLB886Gb8Sb4Yo67uzWUXjI7njbRXp0XY_Y57dvPtXvs_P1u7N6dZ65vFQma0qRK6tdOshDpclYU0q_2ThZlY10nsg4UZqmKEFUpdOy8go0SPAVNaYkdcSezL5jGH7sKE7Yt9FR19ktDbuIWqVDBag0-HUedGGIMZDHMbS9DXsUgAfYeOCFB144w8YcsEA8wEZMsPFP2KgQsF6jxItk_vh6i13T0-bGeqab5M0sX7Ud7f8z-HfuP2P_UtQv_MOcOw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73725103</pqid></control><display><type>article</type><title>Active specific immunotherapy potential for the treatment of large bowel cancer</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Kahan, Barry D. ; Pellis, Neal R. ; Rutzky, Lynne P. ; Wiseman, Floyd ; Tom, Baldwin H.</creator><creatorcontrib>Kahan, Barry D. ; Pellis, Neal R. ; Rutzky, Lynne P. ; Wiseman, Floyd ; Tom, Baldwin H.</creatorcontrib><description>Active specific immunotherapy, harnessing the strength and specificity of the host immune response to destroy neoplastic cells, may offer an ideal surgical adjuvant treatment modality for human colon cancer. Unfortunately, achievement of this goal has been obscured by 1) the effect of excess residual disease to interfere with the host's destructive response, 2) the weak nature of tumor resistance, 3) the potential adverse effect of concomitant treatments such as chemotherapy, and 4) the present limitation of poorly defined immunogens to induce, as well as insensitive assay systems to detect, host sensitization. Recent immunologic and chemical research revealing distinctive surface membrane structures on colon cancer cells suggests that a controlled trial of irradiated, autochthonous cell vaccines (without mycobacterial adjuvants) may provide a new therapeutic tool for Dukes B2 and C stages of human colon cancer.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(197711)40:5+<2740::AID-CNCR2820400949>3.0.CO;2-V</identifier><identifier>PMID: 922711</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Antigens, Neoplasm ; Cell Membrane - immunology ; Colonic Neoplasms - immunology ; Colonic Neoplasms - therapy ; Humans ; Immunotherapy ; Vaccines ; X-Rays</subject><ispartof>Cancer, 1977-11, Vol.40 (S5), p.2740-2746</ispartof><rights>Copyright © 1977 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4639-b6143a7c740f087e9a962fddc286b2cfee9c169b560186c728f307020f8eb96e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/922711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kahan, Barry D.</creatorcontrib><creatorcontrib>Pellis, Neal R.</creatorcontrib><creatorcontrib>Rutzky, Lynne P.</creatorcontrib><creatorcontrib>Wiseman, Floyd</creatorcontrib><creatorcontrib>Tom, Baldwin H.</creatorcontrib><title>Active specific immunotherapy potential for the treatment of large bowel cancer</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Active specific immunotherapy, harnessing the strength and specificity of the host immune response to destroy neoplastic cells, may offer an ideal surgical adjuvant treatment modality for human colon cancer. Unfortunately, achievement of this goal has been obscured by 1) the effect of excess residual disease to interfere with the host's destructive response, 2) the weak nature of tumor resistance, 3) the potential adverse effect of concomitant treatments such as chemotherapy, and 4) the present limitation of poorly defined immunogens to induce, as well as insensitive assay systems to detect, host sensitization. Recent immunologic and chemical research revealing distinctive surface membrane structures on colon cancer cells suggests that a controlled trial of irradiated, autochthonous cell vaccines (without mycobacterial adjuvants) may provide a new therapeutic tool for Dukes B2 and C stages of human colon cancer.</description><subject>Antigens, Neoplasm</subject><subject>Cell Membrane - immunology</subject><subject>Colonic Neoplasms - immunology</subject><subject>Colonic Neoplasms - therapy</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Vaccines</subject><subject>X-Rays</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1977</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkFtv1DAQhS3EbSn8Ax78hKhQlrGdxHFBlZZwq1SxEoIK8TJyvGNIlWyCnaXaf4-XVJXgAfE08pzxOTMfY68ELAWAfC7A6AxELp8Ko7UQxzmcFM9eSp3qyersdVZ_qD_KSkIOYHJzqpawrNcvZHZxiy1uPt9mCwCosiJXX-6zBzFepqeWhbrH7hopk--CrVduan8SjyO51reOt32_2w7Tdwp23PNxmGg7tbbjfgg8dfkUyE59avLB886Gb8Sb4Yo67uzWUXjI7njbRXp0XY_Y57dvPtXvs_P1u7N6dZ65vFQma0qRK6tdOshDpclYU0q_2ThZlY10nsg4UZqmKEFUpdOy8go0SPAVNaYkdcSezL5jGH7sKE7Yt9FR19ktDbuIWqVDBag0-HUedGGIMZDHMbS9DXsUgAfYeOCFB144w8YcsEA8wEZMsPFP2KgQsF6jxItk_vh6i13T0-bGeqab5M0sX7Ud7f8z-HfuP2P_UtQv_MOcOw</recordid><startdate>197711</startdate><enddate>197711</enddate><creator>Kahan, Barry D.</creator><creator>Pellis, Neal R.</creator><creator>Rutzky, Lynne P.</creator><creator>Wiseman, Floyd</creator><creator>Tom, Baldwin H.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197711</creationdate><title>Active specific immunotherapy potential for the treatment of large bowel cancer</title><author>Kahan, Barry D. ; Pellis, Neal R. ; Rutzky, Lynne P. ; Wiseman, Floyd ; Tom, Baldwin H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4639-b6143a7c740f087e9a962fddc286b2cfee9c169b560186c728f307020f8eb96e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1977</creationdate><topic>Antigens, Neoplasm</topic><topic>Cell Membrane - immunology</topic><topic>Colonic Neoplasms - immunology</topic><topic>Colonic Neoplasms - therapy</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Vaccines</topic><topic>X-Rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kahan, Barry D.</creatorcontrib><creatorcontrib>Pellis, Neal R.</creatorcontrib><creatorcontrib>Rutzky, Lynne P.</creatorcontrib><creatorcontrib>Wiseman, Floyd</creatorcontrib><creatorcontrib>Tom, Baldwin H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kahan, Barry D.</au><au>Pellis, Neal R.</au><au>Rutzky, Lynne P.</au><au>Wiseman, Floyd</au><au>Tom, Baldwin H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Active specific immunotherapy potential for the treatment of large bowel cancer</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1977-11</date><risdate>1977</risdate><volume>40</volume><issue>S5</issue><spage>2740</spage><epage>2746</epage><pages>2740-2746</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Active specific immunotherapy, harnessing the strength and specificity of the host immune response to destroy neoplastic cells, may offer an ideal surgical adjuvant treatment modality for human colon cancer. Unfortunately, achievement of this goal has been obscured by 1) the effect of excess residual disease to interfere with the host's destructive response, 2) the weak nature of tumor resistance, 3) the potential adverse effect of concomitant treatments such as chemotherapy, and 4) the present limitation of poorly defined immunogens to induce, as well as insensitive assay systems to detect, host sensitization. Recent immunologic and chemical research revealing distinctive surface membrane structures on colon cancer cells suggests that a controlled trial of irradiated, autochthonous cell vaccines (without mycobacterial adjuvants) may provide a new therapeutic tool for Dukes B2 and C stages of human colon cancer.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>922711</pmid><doi>10.1002/1097-0142(197711)40:5+<2740::AID-CNCR2820400949>3.0.CO;2-V</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 1977-11, Vol.40 (S5), p.2740-2746 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73725103 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Antigens, Neoplasm Cell Membrane - immunology Colonic Neoplasms - immunology Colonic Neoplasms - therapy Humans Immunotherapy Vaccines X-Rays |
| title | Active specific immunotherapy potential for the treatment of large bowel cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T10%3A52%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Active%20specific%20immunotherapy%20potential%20for%20the%20treatment%20of%20large%20bowel%20cancer&rft.jtitle=Cancer&rft.au=Kahan,%20Barry%20D.&rft.date=1977-11&rft.volume=40&rft.issue=S5&rft.spage=2740&rft.epage=2746&rft.pages=2740-2746&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(197711)40:5+%3C2740::AID-CNCR2820400949%3E3.0.CO;2-V&rft_dat=%3Cproquest_cross%3E73725103%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73725103&rft_id=info:pmid/922711&rfr_iscdi=true |